Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lyketsos

Showing results (361-370 of 396) with videos related to

Pageof 40
Sort By:
Neurobiology of Disease|December 3, 2014
Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot studyJennifer M Coughlin, Yuchuan Wang, Cynthia A Munro, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 5, 2015
Time to Response to Citalopram Treatment for Agitation in Alzheimer DiseaseDaniel Weintraub, Lea T Drye, Anton P Porsteinsson, et al.
JAMA|February 20, 2014
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trialAnton P Porsteinsson, Lea T Drye, Bruce G Pollock, et al.
The American Journal of Psychiatry|April 2, 2016
Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD StudyAnne K Leonpacher, Matthew E Peters, Lea T Drye, et al.
Plos One|June 11, 2014
Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trialLea T Drye, David Spragg, D P Devanand, et al.
International Psychogeriatrics|August 26, 2015
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trialPaul B Rosenberg, Lea T Drye, Anton P Porsteinsson, et al.
Brain Injury|February 1, 2017
Head injury serum markers for assessing response to trauma: Design of the HeadSMART studyMatthew E Peters, Vani Rao, Kathleen T Bechtold, et al.
The American Journal of Psychiatry|January 16, 2016
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialLon S Schneider, Constantine Frangakis, Lea T Drye, et al.
Journal of Psychiatric Research|January 7, 2016
Sedation mediates part of Citalopram's effect on agitation in Alzheimer's diseaseJeffery Newell, Jerome A Yesavage, Joy L Taylor, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 30, 2023
Umbrella review and Delphi study on modifiable factors for dementia risk reductionColin Rosenau, Sebastian Köhler, Lion M Soons, et al.
Pageof 40

Showing results (361-370 of 396) with videos related to

Sort By:
Pageof 40
Neurobiology of Disease|December 3, 2014
Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot studyJennifer M Coughlin, Yuchuan Wang, Cynthia A Munro, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 5, 2015
Time to Response to Citalopram Treatment for Agitation in Alzheimer DiseaseDaniel Weintraub, Lea T Drye, Anton P Porsteinsson, et al.
JAMA|February 20, 2014
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trialAnton P Porsteinsson, Lea T Drye, Bruce G Pollock, et al.
The American Journal of Psychiatry|April 2, 2016
Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD StudyAnne K Leonpacher, Matthew E Peters, Lea T Drye, et al.
Plos One|June 11, 2014
Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trialLea T Drye, David Spragg, D P Devanand, et al.
International Psychogeriatrics|August 26, 2015
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trialPaul B Rosenberg, Lea T Drye, Anton P Porsteinsson, et al.
Brain Injury|February 1, 2017
Head injury serum markers for assessing response to trauma: Design of the HeadSMART studyMatthew E Peters, Vani Rao, Kathleen T Bechtold, et al.
The American Journal of Psychiatry|January 16, 2016
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialLon S Schneider, Constantine Frangakis, Lea T Drye, et al.
Journal of Psychiatric Research|January 7, 2016
Sedation mediates part of Citalopram's effect on agitation in Alzheimer's diseaseJeffery Newell, Jerome A Yesavage, Joy L Taylor, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 30, 2023
Umbrella review and Delphi study on modifiable factors for dementia risk reductionColin Rosenau, Sebastian Köhler, Lion M Soons, et al.
Pageof 40